1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple.
Presented By Gunter Von Minckwitz at 2014 ASCO Annual Meeting
The phase III ICE study: Adjudiscloseant Ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer Gunter.
